Infinium Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹130 crore and net profit of ₹10 crore for the September 2026 quarter.
Infinium Pharma (NSE: INFINIUM-ST) closed at ₹303.00 on 20 Nov 2026. Its market capitalisation is ₹472 crore and it trades at 30.5 times earnings.
Incorporated in 2003, Infinium Pharmachem Ltd manufactures and sells Iodian based Pharmaceutical Intermediates
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.